key: cord-0984883-tso5t246
authors: LeBlanc, Emmanuelle V.; Colpitts, Che C.
title: The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus entry inhibitor
date: 2021-06-21
journal: bioRxiv
DOI: 10.1101/2021.06.21.449320
sha: 8a5e3732482ae59e5c082748abf58131fddeb71d
doc_id: 984883
cord_uid: tso5t246

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emphasized the serious threat to human health posed by emerging coronaviruses. Effective antiviral countermeasures are urgently needed as vaccine development against an emerging coronavirus takes time, even in the best-case scenario. The green tea catechin, epigallocatechin gallate (EGCG), has broad spectrum antiviral activity. We demonstrate here that EGCG prevents murine and human coronavirus infection and blocks the entry of lentiviral particles pseudotyped with spike proteins from bat or highly pathogenic coronaviruses. We show that EGCG treatment reduces coronavirus attachment to target cell surfaces. Our results demonstrate the potential for the development of pan-coronavirus attachment inhibitors.

The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected hundreds 25 of millions of people and has resulted in millions of deaths around the world. The COVID-19 26 pandemic, caused by SARS-CoV-2, underscores the severe health threat posed by emerging 27 coronaviruses (CoVs), and makes evident the paucity of antivirals with extended spectrums of 28 activity. SARS-CoV-2 is the third highly pathogenic CoV to emerge in the 21 st century. The 29 abundance and diversity of SARS-related CoVs in bats points to the likelihood of future spillover 30 into human populations [1] . In addition, seasonally circulating common cold CoVs continually 31 burden human health [2] , and cause severe disease in elderly populations [3, 4] , without effective 32 preventative or therapeutic strategies. In order to develop inhibitors that are effective against such 33 a broad range of endemic, pandemic, and emerging CoVs, a conserved step of viral infection needs 34 to be targeted. 35

Most human viruses, including CoVs, initiate primary attachment to cell surfaces through 36 low-affinity but high-avidity interactions with glycans. Heparan sulfate proteoglycans are 37 necessary attachment receptors for the human alphacoronavirus NL63 (HCoV-NL63) [5] , as well 38 as many other human viruses, such as herpes simplex virus (HSV) [6,7], hepatitis C virus (HCV) 39 [8, 9] and human immunodeficiency virus (HIV) [10] . Recently, heparan sulfate has also been 40 identified as a necessary co-factor for SARS-CoV-2 infection [11, 12] . Alternatively, other viruses, 41 including influenza A virus (IAV) and betacoronaviruses HCoV-OC43 and HCoV-HKU1 require 42 sialic acid-containing glycans for attachment and entry [13] [14] [15] . Regardless of the glycan subtype, 43 glycan binding is critical to the primary attachment of many different viruses, facilitating their 44 specific high-affinity interaction with less abundant protein receptors, such as ACE2 for HCoV-45 visualized and counted under a fluorescence microscope (Nikon Eclipse Ts2). 119 MHV A59-GFP virions pre-exposed to EGCG or the DMSO vehicle control for 10 min at 120 37°C in DMEM were used to infect L929 cell monolayers. Inocula were removed 1 h later, and 121 monolayers were overlaid with 1.2% carboxymethylcellulose in DMEM containing 2% FBS. 122

Infected cells were incubated at 33°C in 5% CO2 for 24 h, then fixed prior to counting of GFP-123 positive cells under the fluorescence microscope. 124 VSV-SARS-CoV-2 S virions pre-exposed to EGCG or the DMSO vehicle control for 10 125 min at 37°C in DMEM were used to infect Huh7, A549-ACE2 or Calu-3 cell monolayers in 126 duplicate wells of a 96-well plate. Infected cells were incubated at 33°C in 5% CO2 for 24 h, then 127 fixed with 10% formalin. GFP signals were captured by Nikon Eclipse Ts2, processed using the 128 Python Imaging Library to find the mean grey value, and plotted as percentage of inhibition. 129

In all experiments, half maximal inhibitory concentrations (IC50) were calculated by 130 nonlinear regression analysis using GraphPad Prism (version 9.0; GraphPad Software, Inc.). 

We produced luciferase-encoding lentiviral particles pseudotyped with SARS-CoV-1, CoV-2 and MERS-CoV spike (S) proteins to investigate the effect of EGCG on entry of highly 199 pathogenic coronaviruses. We also generated lentiviral particles pseudotyped with the spike 200 protein of WIV1-CoV, a bat coronavirus that binds to human ACE2 [23]. Huh7 cells were 201 inoculated with CoV S pseudoparticles pre-exposed to EGCG or DMSO for 10 min at 37°C. 202

Inocula were removed after 2 h and replaced with fresh DMEM. After 72 h, cells were lysed and 203 luminescence was measured. EGCG inhibited SARS-CoV-1, SARS-CoV-2, MERS-CoV and 204 WIV1-CoV pseudoparticle entry with IC50 of 2.5, 48.6, 13.7 and 3.8 µM, respectively ( Figure  205 2A). To evaluate the antiviral effect in a more relevant cell type, we generated A549 cells stably 206 expressing human ACE2, the receptor for SARS-CoV-1 and SARS-CoV-2, and isolated a clone 207 with high levels of ACE2 expression and enhanced susceptibility to SARS-CoV-2 S 208 pseudoparticle infection (Supplemental Figure 1) . We found that EGCG also inhibited entry of 209 SARS-CoV-1, SARS-CoV-2, and WIV1-CoV pseudoparticles into A549-ACE2 B9 cells, with 210 IC50 of 15.9, 24.0 and 24.5 µM, respectively (Figure 2A) . independent experiments with duplicates are plotted. 220 221 the effect of EGCG was dependent on MOI. Using the same assay, but with MOI of 0.5, we found 229 that EGCG inhibited VSV-SARS-CoV-2 infection with IC50 ranging from 0.14 to 1.13 µM. These 230 findings demonstrate that the inhibitory activity of EGCG depends on the MOI (Figure 2B 

To confirm that EGCG acts on CoV virions, and not on cells, we performed time-of-addition 239 experiments. Cells were pre-treated with EGCG or DMSO 1 h at 37°C, at which point media was 240 removed and cells were infected with HCoV-229E or HCoV-OC43. Infectivity was determined by 241 plaque assay or immunostaining. Alternatively, cells were infected, and EGCG-or DMSO-242 containing medium was added 2 h post-infection. In either condition, no inhibition of infectivity 243 was observed until the highest concentration of 100 µM EGCG (Figure 3A) . To test if EGCG 244

inhibits CoV attachment, we performed binding assays in which cells were incubated with pre-245 treated virions at 4°C for 1 h to allow for attachment, but not fusion or entry. After cell washing, bound virions were quantified by RT-qPCR (Supplemental Figure 3) . Pre-chilled Huh7 or Calu-247 3 cells were inoculated with HCoV-OC43 or VSV-SARS-CoV-2 treated with DMSO, 10 µM 248 EGCG, or 20 µg/mL heparin, as a control attachment inhibitor [11] . As expected, heparin partially 249 blocked VSV-SARS-CoV-2 binding. We also observed that heparin reduced HCoV-OC43 250 binding, which unlike other coronavirus does not have a known protein receptor but depends on 251 sialic acid, and, as recently reported, glycosaminoglycans for entry [24] . EGCG similarly reduced 252 VSV-SARS-CoV-2 binding to Huh7 and Calu-3 cells (Figure 3B-C) . To protect against emerging CoVs, the identification of broad-spectrum entry inhibitors is a priority. Recently, lactoferrins have been described to disrupt CoV primary attachment, mediated 306 by heparan sulfate interactions, conferring antiviral activity against multiple CoVs in vitro, 307 demonstrating the potential for a pan-coronavirus inhibitor [39] . Small molecules continue to be 308 preferred as drugs in general due to superior pharmacokinetic properties and simpler synthesis 309 

coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for 382 cellular entry

SARS-CoV-2 Cell Entry 386 Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease

A Review of the Antiviral Role of Green Tea Catechins

A Small Molecule Inhibits Virion Attachment to Heparan

Sulfate-or Sialic Acid-Containing Glycans

Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to 395 high titers in vitro and is fully pathogenic in vivo

Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses

The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 415 infection

−)-Epigallocatechin-3-gallate is a new 418 inhibitor of hepatitis C virus entry